InvestorPlace highlights the potential of carefully-selected penny stocks, emphasizing that not all are high-risk investments. It’s important to note that even newer companies can offer legitimate potential, much like the three penny stocks discussed below.
CytomX Therapeutics (CTMX) stands out for its innovative cancer treatments that target cancer cells while minimizing damage to healthy tissue. With drugs in clinical trials and partnerships with major drug makers, CTMX shows promise for the future.
Quhuo (QH) focuses on providing a flexible workforce in China, with potential for expansion into other service-based economies like the U.S. While the stock has seen a downtrend, it presents both risk and opportunity for investors.
Lument Finance Trust (LFT), a real estate investment trust specializing in multi-family properties, offers potential for high returns as the demand for such housing increases. Trading at a low entry price, LFT could be a solid long-term investment.
It’s worth noting that InvestorPlace does not cover penny stocks with a market cap of less than $100 million or low daily trading volume due to the risks involved. As always, investors should exercise caution and conduct thorough research before investing in penny stocks.